Is bortezomib active in patients with mantle cell lymphoma?

Affiliations

Comment

Heinz Ludwig. Nat Clin Pract Oncol. 2007 May.

. 2007 May;4(5):276-7.

doi: 10.1038/ncponc0789. Epub 2007 Mar 20.

¹ 1st Department of Medicine, Center for Oncology and Haematology, Wilhelminenspital, Vienna, Austria. heinz.ludwig@wienkav.at

No abstract available

Comment on

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.
Fisher RI, Bernstein SH, Kahl BS, Djulbegovic B, Robertson MJ, de Vos S, Epner E, Krishnan A, Leonard JP, Lonial S, Stadtmauer EA, O'Connor OA, Shi H, Boral AL, Goy A. Fisher RI, et al. J Clin Oncol. 2006 Oct 20;24(30):4867-74. doi: 10.1200/JCO.2006.07.9665. Epub 2006 Sep 25. J Clin Oncol. 2006. PMID: 17001068 Clinical Trial.